Wilmington Endocrinology pa is categorized under Endocrinologists in Wilmington, NC and active since 2002.
Wilmington Endocrinology pa was established in 2002, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Endocrinologists business, which does work in the B2C market, and is classified as a Endocrinologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Ghobad Azizi, Owner at the company’s single location by writing to 1717 Shipyard Boulevard # 220, Wilmington, North Carolina NC 28403 or by phoning (910) 798-3021. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Wilmington Endocrinology pa |
Contact Person: | Ghobad Azizi, Owner |
Address: | 1717 Shipyard Boulevard # 220, Wilmington, North Carolina 28403 |
Phone Number: | (910) 798-3021 |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Founded: | 2002 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Endocrinologists |
SIC Code: | 8011 |
NAICS Code: | 6211110 |
Share This Business: |
Wilmington Endocrinology pa was started in 2002 to provide professional Endocrinologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Ghobad Azizi, Owner for inquiries that concern Wilmington Endocrinology pa by calling the company number (910) 798-3021, as your correspondence is most welcome. Additionally, the physical location of the single location of Wilmington Endocrinology pa can be found at the coordinates 34.193562,-77.919781 as well as the street address 1717 Shipyard Boulevard # 220 in Wilmington, North Carolina 28403.
For its online presence, you may visit Wilmington Endocrinology pa’s website at and engage with its social media outlets through on Twitter and on Facebook.